HeartSciences shares jump 11.97% after-hours as Ascendiant Capital raises price target to $9.20 with maintained "Buy" rating.
ByAinvest
Monday, Dec 22, 2025 7:28 pm ET1min read
HSCS--
HeartSciences (NASDAQ:HSCS) surged 11.97% in after-hours trading following an updated analyst rating from Ascendiant Capital. Analyst Lucas Ward maintained a "Buy" recommendation for the stock while raising the price target from $9.00 to $9.20, reflecting a 2.22% increase in potential upside. The upgraded target, based on the firm's confidence in the company’s outlook, likely spurred investor optimism and post-market buying activity. The move aligns with the analyst’s reinforced positive stance, which directly supports the stock’s upward trajectory.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet